BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3769387)

  • 1. Indoramin in heart failure: possible adverse effects on hemodynamics and exercise capacity.
    Seth L; Galiè N; Casebolt P; Gimenez H; Malloy M; Franciosa JA
    Clin Pharmacol Ther; 1986 Nov; 40(5):567-74. PubMed ID: 3769387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoramin in severe congestive heart failure.
    Grube E; Manz M; Lüderitz B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S117-23. PubMed ID: 2423784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary observations of chronic indoramin therapy in congestive heart failure.
    Leier CV; Huss P; Parrish D; Binkley PF; Unverferth DV
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S112-6. PubMed ID: 2423783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic and hormonal response to indoramin in congestive heart failure.
    Olivari MT; Garberg VR; Selby T; Cohn JN; Levine TB
    Clin Pharmacol Ther; 1984 Sep; 36(3):297-301. PubMed ID: 6380878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of intravenous indoramin on the hemodynamic adaptation at rest and during exercise in chronic congestive heart failure.
    De Kock MR; Detry JM
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S107-11. PubMed ID: 2423782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic responses to indoramin at rest and during exercise in congestive heart failure.
    Leier CV; Majetich N; Binkley PF; Uverferth DV
    Pharmacotherapy; 1987; 7(3):61-8. PubMed ID: 3628063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic dose-response effects of intravenous indoramin in acute heart failure complicating myocardial infarction.
    Silke B; Nelson GI; Verma SP; Frais MA; Reynolds G; Jackson N; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S102-6. PubMed ID: 2423781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term indoramin therapy in congestive heart failure: a double-blind, randomized, parallel placebo-controlled trial.
    Leier CV; Binkley PF; Randolph PH; Unverferth DV
    J Am Coll Cardiol; 1987 Feb; 9(2):426-32. PubMed ID: 3543093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indoramin in severe cardiac insufficiency. Acute hemodynamic effectiveness].
    Grube E; Lauven GW; Manz M; Lüderitz B
    Dtsch Med Wochenschr; 1986 Mar; 111(11):416-20. PubMed ID: 3948703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDL 17,043: short- and long-term cardiopulmonary and clinical effects in patients with heart failure.
    Rubin SA; Tabak L
    J Am Coll Cardiol; 1985 Jun; 5(6):1422-7. PubMed ID: 3158690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic action of nicorandil in chronic congestive heart failure.
    Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R
    Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic and hormonal effects of central versus peripheral sympathetic inhibition in patients with congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Cardiovasc Pharmacol; 1986; 8(5):973-7. PubMed ID: 2429099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial.
    Franciosa JA; Jordan RA; Wilen MM; Leddy CL
    Circulation; 1984 Jul; 70(1):63-8. PubMed ID: 6373050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.
    Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R
    Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antianginal and haemodynamic effects of alpha 1-adrenoceptor blockade.
    Sheridan DJ; Thomas P; Culling W; Collins P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S144-50. PubMed ID: 2423788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional blood flow and neurohormonal responses to milrinone in congestive heart failure.
    Cody RJ; Kubo SH; Covit AB; Müller FB; Rutman H; Leonard D; Laragh JH; Feldschuh J; Preibisz J
    Clin Pharmacol Ther; 1986 Feb; 39(2):128-35. PubMed ID: 3510799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure.
    Good AP; Unverferth DV; Leier CV
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):529-34. PubMed ID: 2908715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure.
    Franciosa JA; Baker BJ; Seth L
    Am Heart J; 1985 Oct; 110(4):807-13. PubMed ID: 4050653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of minoxidil on hemodynamics in patients with congestive heart failure.
    Franciosa JA; Cohn JN
    Circulation; 1981 Mar; 63(3):652-7. PubMed ID: 7006852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.